Real World Evidence
Real World Evidence (RWE) is the clinical evidence concerning the usage, benefits and risks of marketed pharmaceutical products in clinical practice. RWE is derived from an analysis of Real World Data assembled about a product’s use in the “real world”, collected outside the controls and limitations of conventional randomized clinical trials. RWE fulfills the need for broader information on real-world effectiveness and safety that will impact the reimbursement and utilization of new medications as driven by regulators, public and private payers, prescribers and manufacturers.
Data about real-world patient experience has the potential to improve the quality and delivery of medical care, reduce overall costs and improve outcomes. These data help fill the knowledge gap between clinical trials and actual clinical practice.
In partnership with Allphase Clinical Research Inc.
(www.allphaseclinical.com),
a Contract Research Organization (CRO) that has been designing, implementing and managing Phase IV post-marketing surveillance studies since 2001, Alio Health offers custom-designed and insightful qualitative and quantitative Real World Evidence (RWE) data collection as part of our patient programs.
A more comprehensive article on RWE can be found
here